鶹AV

Our Investigators in the News

Marcel Behr appointed interim director 鶹AV Interdisciplinary Initiative in Infection and Immunity

Founding director Don Sheppard to direct Antimicrobial Resistance Task Force at the Public Health Agency of Canada

Dr. Marcel Behr is an associate leader of the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the MUHC
was appointed interim director of the 鶹AV Interdisciplinary Initiative in Infection and Immunity (MI4), Faculty of Medicine and Health Sciences, 鶹AV, in November 2021. The co-director (Infection) of MI4 prior to this appointment, he will continue to work with Dr. Marie Hudson, also a co-director (Immunity) since 2019.

Read more aboutand MI4 on the 鶹AV website.


Ben Geboe awarded the 2021-2022 Dr. Margaret Becklake Fellowship for research with urban Indigenous populations

The RI-MUHC postdoc is working on a culturally safe framework for TB prevention and care for Indigenous populations in Montreal

Read article


Regular screening for tuberculosis in Inuit communities is cost-effective

A new study from RI-MUHC researchers published in CMAJ recommends regular screening to help reduce outbreaks

Dr. Kevin Schwartzman, Senior Scientist in the Translational Research in Respiratory Diseases Program at the RI-MUHC and first author Aashna Uppal, MScPH.
Dr. Kevin Schwartzman, Senior Scientist in the Translational Research in Respiratory Diseases Program at the RI-MUHC and first author Aashna Uppal, MScPH.

Read article


Tuberculosis Trials Consortium Clinical (2020-2030)

RI-MUHC is being awardedtheTuberculosis Trials Consortium Clinical fromthe Centers for Disease Control and Preventions (CDC) in the amount of $USD 13.5 million.

The purpose of this procurement is to support clinical trials and clinical research on the treatment, diagnosis and prevention of tuberculosis . Emphasis will be given to studies of latent TB infection in low- and medium- TB incidence settings, inclusive of but not limited to the United States and Canada, as well as studies of active TB disease both domestically and internationally.

More information on the TBTC can be found.

TB Centre Members Awarded4-year CIHR Project Grant

Dr. Simon Grandjean Lapierre (PI), Dr. Marcel Behr (Co-I) and Dr. Kevin Schwartzman (Co-I) have been awarded a 4-year project grant from the Canadian Institutes of Health Research for their project titled “Tuberculosis Whole Genome Sequencing for Disease Control in Madagascar - A Cluster Randomized Controlled Trial to Evaluate Different Community-Level Strategies to Reduce the Burden of Disease”.


Some of our Award-winning Investigators

  • Dr Dick Menzies

    Dr. Dick Menzies, Director of the Respiratory Epidemiology Unit at 鶹AV and 鶹AV’s World Health Organization Collaborating Centre in TB Research, has been named recipient of the 2019 CIHR-ICRH/CTS Distinguished Lecturer Award (DLA) in Respiratory Sciences.

    Each year, the DLA Series honours outstanding researchers within the Institute of Circulatory and Respiratory Health (ICRH) research community who have contributed significantly to the advancement of science in their fieldboth in Canada and internationally.

  • Dr Marcel Behr

    Dr. Marcel Behr has been elected to Fellowship in the American Academy of Microbiology. The Academy recognizes excellence, originality, and leadership in the microbiological sciences.

    He has also been elected asTier 1 Canada Research Chair forMycobacterial Genomics.

    Tier 1 Canada Research Chairs (CRC) are for outstanding researchers acknowledged by their peers as world leaders in their fields. A Chair is tenable for seven years and renewable once.

  • Dr Madhukar Pai

    Dr. Madhukar Pai serves as a Consultant to the Bill & Melinda Gates Foundation. He serves on theScientific Advisory Committee of FIND, Geneva; and Access Advisory Committee of TB Alliance. He is on the editorial boards ofLancet Infectious Diseases,PLoS Medicine,eLife,PLoS ONE, International Journal of TB and Lung Disease, among others.

    He is a member of the Royal Society of Canada, and an elected Fellow of the Canadian Academy of Health Sciences.

Back to top